EPIS® Právní systém | Plné znění

XXXXXXXX XXXXXX (XX) 2019/831

xx dne 22. xxxxxx 2019,

xxxxxx xx xxxx xxxxxxx XX, XXX x X xxxxxxxx Evropského xxxxxxxxxx x Xxxx (XX) č. 1223/2009 x xxxxxxxxxxxx xxxxxxxxxxx

(Xxxx s xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x xxxxxxx xx Smlouvu x xxxxxxxxx Xxxxxxxx xxxx,

x xxxxxxx xx nařízení Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x. 1223/2009 ze xxx 30. xxxxxxxxx 2009 x xxxxxxxxxxxx xxxxxxxxxxx (1), x xxxxxxx xx čl. 15 xxxx. 1, čl. 15 xxxx. 2 xxxxxx pododstavec x xx. 31 xxxx. 1 uvedeného xxxxxxxx,

xxxxxxxx x xxxxx důvodům:

(1)

Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x. 1272/2008 (2) xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxxxx jako xxxxx karcinogenních, mutagenních xxxx xxxxxxxxx xxx xxxxxxxxxx (CMR) na xxxxxxx xxxxxxxxx posouzení Xxxxxx xxx posuzování xxxxx Xxxxxxxx agentury xxx xxxxxxxx xxxxx. Xxxxx xxxx klasifikovány xxxx xxxxx CMR xxxxxxxxx 1 X, xxxxx XXX xxxxxxxxx 1X xxxx látky XXX xxxxxxxxx 2 x xxxxxxxxxx xx xxxxxx xxxxxx x xxxxxx xxxxxxxxxxxx XXX.

(2)

Xxxxxx 15 xxxxxxxx (XX) x. 1223/2009 xxxxxxxx xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxx xxxxx 3 přílohy XX xxxxxxxx (XX) č. 1272/2008 (xxxxx XXX) xxxx xxxxx XXX kategorie 1 X, xxxxxxxxx 1B xxxx kategorie 2. Xxxxx CMR však xxxx xxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, pokud xxxx xxxxxxx xxxxxxxx xxxxxxxxx x xx. 15 xxxx. 1 xxxxx xxxx xxxx x xx. 15 odst. 2 xxxxxx xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Xxxxx xxxxxxxxx xx provádí nařízení (XX) x. 1223/2009. Vykládat xxxxx Xxxx, xxxxxx xxxxxx 15 xxxxxxxx (XX) x. 1223/2009, je oprávněn xxxxx Xxxxxx dvůr Xxxxxxxx unie.

(3)

X xxxxx xxxxxxxxxx xxxxxxxxx xxxxxx látek XXX x xxxxx xxxxxxxxx xxxx, zajištění xxxxxx xxxxxxx zejména pro xxxxxxxxxxx xxxxxxxx a příslušné xxxxxxxxxxxx xxxxxx, jakož x xxxxxxxxx xxxxxx úrovně xxxxxxx xxxxxxxx xxxxxx xx xxxxxxx látky XXX xxxx být xxxxxxxx xx xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xxxxxx xx xxxxxxx látek xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx nařízení. Xxxxx xxxx splněny xxxxxxxx xxxxxxxxx x xx. 15 xxxx. 1 druhé xxxx xxxx v čl. 15 xxxx. 2 xxxxxx xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009, xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxx povolených látek x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx by xxxx xxx xxxxxxxxxxxxx způsobem xxxxxxx.

(4)	Xxxx xxxxxxxx xx xxxxxxxx na xxxxx, xxxxx byly podle xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxxx jako xxxxx XXX xx dni 1. xxxxxxxx 2018, kdy xx xxxxx použitelným nařízení Xxxxxx (XX) 2017/776 (3).

(5)

Xxxxx xxx x xxxxxx xxxxx XXX, xxx xxx xxxx předložena žádost x xxxxxxxxx použití v kosmetických xxxxxxxxxxx, xxxxxx xxxxxxxxx, xx xxxx splněny xxxxxxx podmínky xxxxxxxxxx x xx. 15 odst. 1 druhé xxxx xxxx x xx. 15 xxxx. 2 druhém pododstavci xxxxxxxx (ES) x. 1223/2009. Xx xx xxxx xxxxx Xxxxxxxxxx-15, Chloroacetamide, xxxxxxxxxxxxxx, xxxxxxxxxxxx, sloučenin xxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxxxx.

(6)

Xxxxx xxxxxxxxxx-3-xxxxxxxxxxxxxxxxx, xxxxx xxxxx podle Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxxxxx (XXXX) xxx Xxxxxxxxxx-15, xx x xxxxxxxx době xxxxxxx v položce 31 xxxxxxx X xxxxxxxx (ES) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx xx 0,2 % v přípravku xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxx-15 xx směs cis- x xxxxx-xxxxxxx, xxxxx xxx-xxxxxx xxx xxxxxxxxx Xxxxxx (XX) x. 790/2009 (4) xxxxxxxxxxxx xxxx xxxxx XXX kategorie 2. Xxxx klasifikace se xxxxx xxxxxxxxxxx xxx 1. xxxxxxxx 2010. X xxxxxxx s čl. 15 xxxx. 1 xxxxxx xxxxx xxxxxxxx (XX) č. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx jako xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xxxx-xx xxxxxxxxxx Xxxxxxxx xxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxx (xxxx xxx „VVBS“) x xxxxxxxx xxxx bezpečná pro xxxxxxx x xxxxxxxxxxxx přípravcích. Xx xxxxx 13. x 14. xxxxxxxx 2011 vydal XXXX xxxxxxx xxxxxxxxxx týkající xx látky Quaternium-15 (xxx-xxxxxx) (5), ve xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx dostupných xxxxx xxxxx stanovit xxxxxxxxxx použití xxxxx Xxxxxxxxxx-15 x xxxxxxxxxxxx přípravcích. X xxxxxxx na xxxxxxxxxxx xxx-xxxxxxx xxxxxxxxxx x xxxxx Xxxxxxxxxx-15 xxxx látky XXX xxxxxxxxx 2 x xx stanovisko XXXX xx měla xxx xxxxx Xxxxxxxxxx-15 xxxxxx xx seznamu konzervačních xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxx v příloze X xxxxxxxx (XX) č. 1223/2009 a doplněna xx xxxxxx xxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx II xxxxxxxxx xxxxxxxx.

(7)

Xxxxx 2-chloracetamid, jejíž xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxx, xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 41 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xxxx xxxxx povolená x xxxxxxxxxxx xx 0,3 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxxxxxxx byla xxxxx xxxxxxxx (ES) x. 1272/2008 xxxxxxxxxxxxx jako xxxxx XXX kategorie 2. Xxxx klasifikace xx stala xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010, xxx xx datum, xxx xx xxx xxxxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxx XX, XXX a IV xxxxxxxx (XX) x. 1272/2008. V souladu x xx. 15 xxxx. 1 druhou xxxxx xxxxxxxx (XX) x. 1223/2009 xxxx xxx xxxxx klasifikovaná xxxx xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx přípravcích, xxxx-xx xxxxxxxxxx VVBS x xxxxxxxx xxxx xxxxxxxx pro xxxxxxx v takových xxxxxxxxxxx. Xxx 22. xxxxxx 2011 vydal XXXX xxxxxxx stanovisko xxxxxxxx xx xxxxx Xxxxxxxxxxxxxxx (6), ve kterém xxxxxx k závěru, že xx xxxxxxx xxxxxxxxxx xxxxx není tato xxxxx xxx použití x xxxxxxxxxxx xx 0,3 % xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxxxxx xxxxxxxx. X xxxxxxx xx xxxxxxxxxxx xxxxx Xxxxxxxxxxxxxxx jako xxxxx CMR xxxxxxxxx 2 x xx xxxxxxxxxx XXXX xx měla xxx xxxx xxxxx xxxxxx xx xxxxxxx xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx na seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(8)

Xxxxx xxxxxxxxxxxxx xx x xxxxxxxx době xxxxxxx x xxxxxxx 7 xxxxxxx III xxxxxxxx (XX) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 35 % v přípravku xxxxxxxxxxx x xxxxxxx. Xxxxxxxxxxxxx xxx xxxxx xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010. X xxxxxxx x xx. 15 odst. 1 xxxxxx větou xxxxxxxx (XX) x. 1223/2009 může xxx xxxxx xxxxxxxxxxxxx xxxx kategorie 2 xxxxxxx x xxxxxxxxxxxx přípravcích, xxxx-xx xxxxxxxxxx XXXX x xxxxxxxx xxxx bezpečná xxx xxxxxxx v takových xxxxxxxxxxx. Xxx 11. xxxxxxxx 2012 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx xx xxxxx xxxxxxxxxxxxx (7). Xxx 25. xxxxxx 2015 xxxxx XXXX xxxx stanovisko (8), které xxxx revidováno xxx 28. xxxxx 2015. X xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxxx XXXX x xxxxxx, xx xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxx do 35 % x xxxxxx na xxxxx x xxxx xxxxxxx xx xxxxxxxx xxxxxx xxxx považováno xx xxxxxxxx xxx xxxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxx XXX kategorie 2 x xx stanovisko XXXX x xxxxxxxx x xxxx, že xxxxxx známa x xx xxxxxxxxxx VVBS xxxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx v kosmetických přípravcích, xx tato xxxxx xxxx xxx xxxxxx xx seznamu látek xxxxxxxxxxxxx omezení x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx na xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(9)

Xxxxx xxxxxxxxxxx xx x xxxxxxxx xxxx uvedena x xxxxxxx 13 xxxxxxx III xxxxxxxx (ES) č. 1223/2009 xxxx xxxxx povolená x xxxxxxxxxxx xxx tvrzení xxxxx x xxxxxxxxxxx do 5 % v přípravku připraveném x xxxxxxx. V současné xxxx xx také xxxxxxx x xxxxxxx 5 xxxxxxx X xxxxxxxx (ES) x. 1223/2009 xxxx látka xxxxxxxx x xxxxxxxxxxx pro xxxxx xxxxxxx v koncentraci xx 0,1 % x x xxxxxx xxxxxxxxxxx x xxxxxxxxxxx do 0,2 %. Xxxxxxxxxxx xxx klasifikován xxxx xxxxx CMR xxxxxxxxx 1X xxxxxxxxx Xxxxxx (EU) x. 605/2014 (9). Xxxx xxxxxxxxxxx xx xxxxx použitelnou xxx 1. xxxxx 2016. V souladu x xx. 15 xxxx. 2 druhým pododstavcem xxxxxxxx (XX) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx jako xxxxx XXX kategorie 1 A xxxx 1X v kosmetických xxxxxxxxxxx xxxxxxxxx použity, xxxxx xxxx xxxx, xx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX, xxxxxxx xxxxxx podmínky xxxxxx xxxxxxxx, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx alternativní xxxxx, xx byla xxxxxx xxxxxx na určité xxxxxxx xxxxxxxxx xxxxxxxxx xx známou xxxxxxxx x xx xxxx tato xxxxx VVBS xxxxxxxxxx x xxxxxxxx xxxx xxxxxxxx. Xxx 7. listopadu 2014 dospěl XXXX xx xxxx xxxxxxxxxx (10) x xxxxxx, že „xxx xxxxxxx nebo xxxxxxxx xxxxx mohou xxx xxxxxxxx xxxxxxx xxxxxxxxx xxx xxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxx 2,2 % xxxxxxx xxxxxxxxxxxx“. Xxxxxxx xxxx xxxxxx xxxxxxxxx, xx xxxxxx k dispozici xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx xxxxxxx nehtů, xxx xx být xxxxxxxxxxx xxxxx xx xxxxxxx látek xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009. Xxxxxxxx x xxxx, xx xxxxxx xxxxxx xxxxxx xx jiná xxxxxxx xxxxxxxxxxxx, xxxx xx xxx xxxx xxxxx xxxxxx ze seznamu xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx X xxxxxxxxx xxxxxxxx. Formaldehyd xx xxx být xxxxxx doplněn na xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(10)

Xxxxxxxxxx xxxxxxxx perborité x xxxxxxxxxxx xxxxx xxxxx xxxx xxxxx xxxxxxxxxx xxxxxxx xxxxxx, xxxxx xxxx x xxxxxxxx době xxxxxxx x xxxxxxx 12 xxxxxxx III xxxxxxxx (XX) x. 1223/2009. Tyto xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx CMR xxxxxxxxx 1B xxxxxxxxx (XX) x. 790/2009. Xxxx xxxxxxxxxxx se stala xxxxxxxxxxx xx xxx 1. xxxxxxxx 2010. Na použití xxxxxx xxxxx v oxidačních xxxxxxxxxxx x xxxxxxx vlasů xxxx xxxxxx xxxxxx x xxxxxxxxx xx. 15 xxxx. 2 xxxxxxx xxxxxxxxxxx nařízení (XX) x. 1223/2009. Xxx 22. xxxxxx 2010 xxxxxx XXXX xx xxxx xxxxxxxxxx (11) x xxxxxx, xx „obecná xxxxxxx xxxxxx pro xxxxx, které xxxxxxxx xxxxxxx xxxxxx, by xx měla xxxxxxxxx xx xxxxxxxxxx sodný x xxxxxxxx xxxxxxxxxx a že xxxxxxx xxxxxxxxxxx xxxxxxx xxxx xxxxxx v oxidačních xxxxxxxxxxx k barvení xxxxx x xxxxxxxxxxx xxxxxxx 3 % xx xxxxx xxxxxxxxxxxxx xxxxxx xxx zdraví xxxxxxxxxxxx“. Protože však xxxxxx xxxxxxxxx, že xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx látky xxx xxxxx oxidace xxxxx, sloučeniny kyseliny xxxxxxxxx a perboritany sodné xx xxxx xxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx III xxxxxxxx (XX) x. 1223/2009 a doplněny xx xxxxxx xxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(11)

Xxxxx jde x xxxxxx xxxxx, jež byly xxxxxxxxxxxxx xxxx látky XXX xxxxx nařízení (XX) č. 1272/2008 a pro xxx xxxx podána xxxxxx x xxxxxxxxx čl. 15 xxxx. 1 xxxxx xxxx xxxxxxxx (ES) x. 1223/2009, xxxx xxxxxxxxx, xx xxxxxxxx xxxxxxxxx x xxxxxxxx xxxxxxxxxx je xxxxxxx. Xx se xxxx xxxxx Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx, Furfural x Xxxxxxxxxxxxxxx xxxxxxxxx.

(12)

Xxxxx difenyl(2,4,6-trimetylbenzoyl)fosfin xxxx, xxxxx xxxxx podle XXXX xxx Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx (XXX), xxxx v současné xxxx xx příloh nařízení (XX) č. 1223/2009 xxxxxxxx. Xxxx xxxxx xxxx xxxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 2 xxxxxxxxx Xxxxxx (XX) x. 618/2012 (12). Tato klasifikace xx stala použitelnou xxx 1. xxxxxxxx 2013. Xxx 27. xxxxxx 2014 vydal XXXX xxxxxxx xxxxxxxxxx (13), v němž xxxxxx x xxxxxx, xx xxxxx XXX xx xxxxxxxx xxx xxxxxxx xxxx přípravek x xxxxxxxx xxxxx v koncentraci xx 5,0 %, xxxxx xx xxx o látku xxxxx xxxxxxxxxxxxxxx kůži. Xxxxxxxx x xxxxxxxxxxxxxxxx účinkům TPO xx xxxx x xxxxxxxx xxxxxx xxxxxxxx v důsledku xxxxx s kůží xxx xxxxxxxx xxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxxxxxxx xx používání TPO xxxx xxx xxxxxxx xx xxxxxxxxxxxxx xxxxxxxxx. X xxxxxxx na tyto xxxxxxxxxxx xx xxxxx XXX měla xxx xxxxxxxx xx xxxxxx xxxxx podléhajících xxxxxxx x xxxxxxx III xxxxxxxx (XX) č. 1223/2009 pro xxxxxxxxxxxxx xxxxxxx x xxxxxxxxx xxxxxxx xxxxx v koncentraci xxxxxxx 5 %.

(13)

Látka 2-furaldehyd, xxxxx název xxxxx XXXX zní Xxxxxxxx, xx xxxxxxx xxxx xxxxx nebo xxxxxxxxxx xxxxxx v kosmetických xxxxxxxxxxx x x xxxxxxxx xxxx xxxx xxxxxxxx do příloh xxxxxxxx (XX) x. 1223/2009. Xxxx xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 xxxxx nařízení (XX) x. 1272/2008. Xxxx klasifikace xx xxxxx použitelnou xxxx 1. xxxxxxxxx 2010. Xxx 27. xxxxxx 2012 dospěl XXXX xx svém xxxxxxxxxx (14) k závěru, xx xxxxxxx látky Furfural x xxxxxxxxxxx do 10 xxx (0,001 %) v přípravku xxxxxxxxxxx k použití, xxxxxx xxxxxxxxx xxx ústní xxxxxxx, xxxxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxxxxxxxx. X xxxxxxx na xxxxxxxxxxx xxxxx Xxxxxxxx xxxx xxxxx XXX kategorie 2 a na stanovisko XXXX xx xxxxx Xxxxxxxx x xxxxxxxxxxx xxxxxxx 0,001 % xxxx xxx xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009.

(14)

Látka polyhexamethylen-biguanid-hydrochlorid (XXXX), xxxxx xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxx xxxxxxxxx, je x xxxxxxxx xxxx uvedena xx seznamu xxxx xxxxxxxxxxx přísada x xxxxxxx 28 přílohy X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxx xxxxxxx 0,3 %. Xxxx xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 nařízením Xxxxxx (EU) x. 944/2013 (15). Xxxx xxxxxxxxxxx se xxxxx xxxxxxxxxxx xxx 1. xxxxx 2015. Xxx 18. xxxxxx 2014 xxxxxx XXXX xxxxxxxxxx (16), xx xxxxxx xxxxxx x xxxxxx, že xx xxxxxxx xxxxxxxxxx xxxxx xxxxx látku PHMB xxxxxxxxx xx xxxxxxxxx xxx xxxxxxxxxxxx, pokud xx x xxxxxxxxxxx xxxxxxx 0,3 % xxxxxxx jako xxxxxxxxxxx přísada x xxxxxxxxxx xxxxxxxxxxx přípravku. Ve xxxx xxxxxxxxxx však XXXX xxxxxx dospěl x xxxxxx, xx xxxxxxxx xxxxxxx xx mohlo xxx xxxxxxxx xx xxxxx koncentraci xxxxxxx x/xxxx omezení, pokud xxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxxxx, a že xxxx xxxxxxxxx xxxxxx dermální xxxxxxxx xxxxxxxx xx xxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx. Xxx 7. xxxxx 2017 xxxxxx XXXX xxxx xxxxxxxxxx (17), ve xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx xxxxxxxxxxxx xxxxx xx použití XXXX jako konzervační xxxxxxx xx xxxxx xxxxxxxxxxxx přípravcích x xxxxxxxxxxx xx 0,1 % xxxxxxxx xx bezpečné, xxx xxxx xxxxxxx xx xxxxxxxx xx xxxxxxxxxxxx. X xxxxxxx xx klasifikaci XXXX xxxx xxxxx XXX kategorie 2 x xx nové xxxxxxxxxx XXXX by xxxxx XXXX xxxx xxx xxxxxxxx jako xxxxxxxxxxx xxxxxxx xx všech xxxxxxxxxxxx přípravcích, x xxxxxxxx xxxxxxxx, xxx mohou xxxx k expozici xxxx xxxxxxxxx xxxxxxxxx xxx xxxxxxxxxx, v koncentraci xxxxxxx 0,1 %. Podmínky xxxxxxxxx x xxxxxxx V nařízení (XX) x. 1223/2009 xx xxxxx xxxx být xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(15)

Xxxxx jde x xxxxxx xxxxxxx xxxxx, xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx CMR xxxxx xxxxxxxx (XX) x. 1272/2008, žádná žádost xx xxxxxxxxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx nebyla xxxxxxxxxx. Xxxx xxxxx xx měly xxx xxxxxxxx na xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX xxxxxxxx (ES) x. 1223/2009 a případně vyňaty xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx látek x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx. Xx xx xxxx xxxx xxxx xxxxxxxxx xxxxxxxxx boru, které xxxx x xxxxxxxx xxxx xxxxxxx v položkách 1a x 1x přílohy XXX xxxxxxxx (XX) č. 1223/2009.

(16)

Xxxxxxx xxxxxxxxxx xxxx, xxxxx xxxx x xxxxxxxx době xxxxxxx v položkách 1x x 1x xxxxxxx XXX xxxxxxxx (ES) x. 1223/2009, x xxxxxxxxxx-xxxxxxxxxxxxx xxxx xxxxxxxxx (XX) x. 790/2009 xxxxxxxxxxxxx xxxx látky XXX xxxxxxxxx 1B. Tato xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xx dni 1. xxxxxxxx 2010. X xxxxxxx s čl. 15 xxxx. 2 druhým xxxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X xxxx 1X x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxx, xxxxx xxxx poté, xx xxxx klasifikovány xxxx xxxxx XXX, xxxxxxx xxxxxx xxxxxxxx. Xxx 22. xxxxxx 2010 xxxxx XXXX xxxxxxxxxx (18), x xxxx xxxxxx x xxxxxx, xx xxxxxxx sloučeniny xxxx, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx x xxxxxxxxx 1x x 1x přílohy XXX zmíněného nařízení, xxxx xxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xx xxxxxxxx xxxxxxxx xxxxxxxx. Xxxxxxx xxxxxx xxxxxx xxxxxx xx xxxxxx xxxxxxx a nebylo xxxxxxxxx, xx xxxxxx x xxxxxxxxx xxxxx vhodné xxxxxxxxxxxx xxxxx xxx xxxxx xxxxxxxxxxxx xxxxxxx uvedených x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009, xxxx xx xxx uvedené xxxxxxxxxx xxxx vyňaty xx seznamu xxxxx xxxxxxxxxxxxx xxxxxxx v příloze XXX xxxxxxxxx xxxxxxxx x xxxxxxxx na seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze II xxxxxxxx (ES) č. 1223/2009. Xxxxx jde o dibutylcín-hydrogenborát, xxxxxx xxxxxx xxxxxx xx xxxxxx xxxxxxx x XXXX xx neshledal xxxx xxxxxxxxx. Xxxxxxx xxxxx xx proto xxxx být xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxx (XX) č. 1223/2009.

(17)

Ustanovení xx. 31 xxxx. 1 nařízení (ES) x. 1223/2009 xxxxxxx, že xxxxxxxxxxx-xx xxxxxxx xxxxxxxx xxxxx v kosmetických přípravcích xxxxxxxxxxx riziko xxx xxxxxx xxxxxx, které xxxxxxxx xxxxx na xxxxxx Společenství, xxxx Xxxxxx xx xxxxxxxxxx x XXXX odpovídajícím xxxxxxxx xxxxxx xxxxxxx II xx XX xxxxxxxxx xxxxxxxx. Komise xxxxxxxxxxxx XXXX xxxxxxx xxxxxxxxxxx xxxxxxxx látek, xxxxx xxxx z chemického xxxxxxxx xxxxxxx xxxxxx klasifikovaným xxxx xxxxx XXX xxxxxxxxx 1 X, 1B xxxx 2. Xx xx xxxx xxxxxxxx xxxxxxxxx boru, jakož x xxxxx xxxxxxxxxxxxxxx a methylenglykol.

(18)

Xxxxxxx xxxxxxxxxx boru, v současné xxxx uvedené v položkách 1x x 1x přílohy XXX nařízení (XX) x. 1223/2009, xxxx xxx xxxxxxxxxx xxxxxxx x 16. xxxx xxxxxxxxxx, nebyly xxxxxxxxxxxxx xxxx xxxxx XXX. Xxx 12. prosince 2013 xxxxx XXXX xxxxxxxxxx xxxxxxxx xx xxxxxxxx, xxxxxxxxxxxxx a oktaboritanů (19), ve xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx xxxxx, xxxxxx jako xxxxxxx xxxx xxxx xxxxxx xxxxxxxx borité, xxxx xx XXX-xxxxx, XXXX-xxxxxxx, xxxxxxx draselný, xxxxxxxxxxxxxxx-xxxxx x xxxxxxx xxxxxxxxx, xxxxxxxxx ve xxxxxxx xxxxxxxxx na xxxxxxxx xxxxxxx, a proto xx xx xxxxxx xxxxxxx xxxxxx xxx xxxxxxxx xxxxxxx měla xxxxxxxxx xx xxxxx skupinu xxxxxxxx, tetraboritanů a oktaboritanů. Xxxxxxxx xxxxxx xxxx xxxxxxxxx (XX) x. 790/2009 xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1X. Xxxx klasifikace xx xxxxx xxxxxxxxxxx ke xxx 1. xxxxxxxx 2010. Xxxx xxxxxxx boritanů, tetraboritanů x xxxxxxxxxxxx, x xxxxxxxx xxxxx x xxxxxxx xxxxxxx, xxxxx xxxx klasifikovány xxxx xxxxx XXX, xxxxxx xxxx xxxxxxx xxxx xxxx xxxxxx xxxxxxxx xxxxxx xx xxxx xxx x xxxxxxx xx xxxxxxxxxx VVBS xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx v příloze XXX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX uvedeného xxxxxxxx.

(19)

Xxxxx xxxxxxxxxxxxxxx xx x xxxxxxxx xxxx uvedena xx xxxxxxx x xxxxxxx 5 xxxxxxx X xxxxxxxx (XX) x. 1223/2009, xxxxx na xxxxxx xx xxxxxxxxxxxx xxxxxx xxxxxxxxxxxxx xxxx xxxxx XXX. Látka xxxxxxxxxxxxxx xxxx v současné xxxx do xxxxxx xxxxxxxx (XX) č. 1223/2009 xxxxxxxx. Xx xxxxx 26. x 27. xxxxxx 2012 xxxxxx XXXX xxxxxxxxxx xxxxxxxx xx methylenglykolu (20), ve xxxxxx xxxxxxxx, xx xxxxxxxxxxxxxx xx xx xxxx různých podmínek xxxxxx reverzibilní, což xxxx x xxxx přeměně xx xxxxxxxxxxx xx xxxxxxx roztocích, x xx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxx, xxx vede x xxxx xxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxx sušením. X xxxxxxx xx xxxxxxxxxx XXXX xxxxxxxx potenciální xxxxxx xxx lidské xxxxxx xxxxxxxxxxx x xxxxxxx xxxxxx látek x xxxxxxxxxxxx xxxxxxxxxxx. Xxxxxxxxxxxxxxx xx xxxxx měl xxx xxxxx ze xxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx xx xxxx být doplněny xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx II xxxxxxxxx xxxxxxxx.

(20)	Xxxxxxxx (XX) č. 1223/2009 xx xxxxx mělo xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(21)	Xxxxxxxx stanovená xxxxx xxxxxxxxx xxxx x xxxxxxx xx xxxxxxxxxxx Xxxxxxx xxxxxx pro kosmetické xxxxxxxxx,

XXXXXXX XXXX NAŘÍZENÍ:

Xxxxxx 1

Xxxxxxx XX, XXX x X xxxxxxxx (XX) č. 1223/2009 xx xxxx v souladu x xxxxxxxx xxxxxx xxxxxxxx.

Xxxxxx 2

Xxxx xxxxxxxx xxxxxxxx x xxxxxxxx dvacátým xxxx xx xxxxxxxxx x Xxxxxxx xxxxxxxx Evropské xxxx.

Xxxx xxxxxxxx je xxxxxxx x xxxxx rozsahu x xxxxx použitelné xx xxxxx xxxxxxxxx xxxxxxx.

V Bruselu xxx 22. května 2019.

Xx Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;342, 22.12.2009, s. 59.

(2) Nařízení Evropského parlamentu x&xxxx;Xxxx (XX) č. 1272/2008 xx dne 16. prosince 2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí, x&xxxx;xxxxx x&xxxx;xxxxxxx xxxxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx nařízení (XX) x.&xxxx;1907/2006 (Xx.&xxxx;xxxx.&xxxx;X&xxxx;353, 31.12.2008, s. 1).

(3) Nařízení Komise (XX) 2017/776 ze xxx 4.&xxxx;xxxxxx&xxxx;2017, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;116, 5.5.2017, x.&xxxx;1).

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (ES) x.&xxxx;790/2009 ze xxx 10.&xxxx;xxxxx&xxxx;2009, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku xxxx xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;235, 5.9.2009, s. 1).

(5) SCCS/1344/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_077.pdf.

(6)&xxxx;&xxxx;XXXX/1360/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_053.xxx.

(7) SCCS/1408/11, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_118.xxx

(8) SCCS/1547/15, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_170.xxx

(9)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (EU) x.&xxxx;605/2014 ze xxx 5.&xxxx;xxxxxx&xxxx;2014, xxxxxx se xxx účely xxxxxxxx xxxxxxxxxxxx výrazů týkajících xx xxxxxxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxx v chorvatštině x&xxxx;xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx pokroku xxxx xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí (Úř. věst. L 167, 6.6.2014, x.&xxxx;36).

(10)&xxxx;&xxxx;XXXX/1538/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_164.xxx

(11) SCCS/1345/10, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_031.xxx

(12)&xxxx;&xxxx;Xxxxxxxx Komise (XX) x.&xxxx;618/2012 xx dne 10.&xxxx;xxxxxxxx&xxxx;2012, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Úř. věst. L 179, 11.7.2012, x.&xxxx;3).

(13)&xxxx;&xxxx;XXXX/1528/14, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_149.pdf.

(14)&xxxx;&xxxx;XXXX/1461/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_083.xxx

(15)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;944/2013 ze xxx 2.&xxxx;xxxxx&xxxx;2013, xxxxxx xx xxx xxxxx přizpůsobení xxxxxxxxxxxxxxxxxx xxxxxxx mění xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Úř. věst. L 261, 3.10.2013, x.&xxxx;5).

(16)&xxxx;&xxxx;XXXX/1535/14, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_157.pdf

(17)&xxxx;&xxxx;XXXX/1581/16, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxx/xxxxxx/xxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_204.xxx

(18)&xxxx;&xxxx;XXXX/1249/09, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_027.xxx

(19)&xxxx;&xxxx;XXXX/1523/13, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_146.xxx

(20) SCCS/1483/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_097.xxx

PŘÍLOHA

Příloha II xx xxxx takto:

doplňují xx xxxx xxxxxxx, xxxxx xxxxx:

Xxxxxxxxxx číslo	Identifikace xxxxx
Xxxxxxxxxx číslo	Xxxxxxxx xxxxx/XXX	Xxxxx XXX	Xxxxx ES
a	b	c	d
„1385	Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantan-chlorid (xxx-XXXX)	51229-78-8	426-020-3
1386	Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX), xxxxxxxxxx-15	51229-78-8	426-020-3
1387	2-Xxxxxxxxxxxxx	79-07-2	201-174-2
1388	Xxxxxxxxxxxxxxxxxxxxxxxxxxx	556-67-2	209-136-7
1389	Xxxxxxxxxxxxx; xxxxxxxxxxxxxxx	75-09-2	200-838-9
1390	2,2′-((3,3′,5,5′-xxxxxxxxxxx-(1,1′-xxxxxxx)-4,4′-xxxx)-xxx(xxxxxxxxxxx))-xxxxxxxxx	85954-11-6	413-900-7
1391	Xxxxxxxxxxx; ethanal	75-07-0	200-836-8
1392	1-Cyklopropyl-6,7-difluor-4-oxo-1,4-dihydrochinolin-3-karboxylová kyselina	93107-30-3	413-760-7
1393	N-methyl-2-pyrrolidon; 1-xxxxxxxxxxxxxxxx-2-xx	872-50-4	212-828-1
1394	Xxxxxxxxxxxx; oxid xxxxxx	1303-86-2	215-125-8
1395	Xxxxxxxx xxxxxx [1] Xxxxxxxx boritá [2]	10043-35-3 [1] 11113-50-1 [2]	233-139-2 [1] 234-343-4 [2]
1396	Xxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxxx x xxxx x xxxxxx xxxxxxxx xxxxxx, včetně:
	Oktaboritan xxxxxxx xxxxxxxxxxx [1]	12280-03-4 [1]	234-541-0 [1]
	2-xxxxxxxxxxxx, monoester x xxxxxxxxx boritou [2]	10377-81-8 [2]	233-829-3 [2]
	(2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxxxxxxx [3]	68003-13-4 [3]	268-109-8 [3]
	Xxxxxxx xxxxxxxx, xxxxxxxx sůl xxxxxxxx xxxxxx [4]	12712-38-8 [4]	603-184-6 [4]
	Xxxxxxxxxxxxxxx-xxxxx [5]	-[5]	— [5]
	Boritan xxxxxxxxx [6]	1332-07-6 [6]	215-566-6 [6]
	Xxxxxxx xxxxx, xxxxxxxxxxxx xxxxxxx xxxxxxx; xxxxx xxx xxxxxxxx xxxxxx [7]	1330-43-4 [7]	215-540-4 [7]
	Xxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxx [8]	12267-73-1 [8]	235-541-3 [8]
	Sodná sůl xxxxxxxx xxxxxxxxxxx [9]	13840-56-7 [9]	237-560-2 [9]
	Xxxxxxxxxxxx xxxxxxx xxxxxxxxxx; xxxxx dekahydrát [10]	1303-96-4 [10]	215-540-4 [10]
	Tetraboritan xxxxxxx xxxxxxxxxxx; xxxxx xxxxxxxxxxx [11]	12179-04-3 [11]	215-540-4 [11]
1397	Xxxxxxxxxx xxxxx [1] xxxxxxxxxxxxxxxxx xxxxx; xxxxxxxxxxxxx xxxxx [2]	15120-21-5 [1]	239-172-9 [1]
1397		7632-04-4 [2] 10332-33-9 [2] 10486-00-7[2]	231-556-4 [2]
1398	Xxxxxxxx xxxxxxxxx (X3XX2(X2)), xxxxxxxxx xxx, xxxxxxxxx [1]	13517-20-9 [1]	239-172-9 [1]
	kyselina xxxxxxxxx, xxxxx xxx, xxxxxxxxxxx [2]	37244-98-7 [2]	234-390-0 [2]
	kyselina xxxxxxxxx (HBO(O2)), xxxxx xxx, tetrahydrát xxxxxxxxxxxxx xxxxx xxxxxxxxxx [3]	10486-00-7 [3]	231-556-4 [3]
1399	Kyselina xxxxxxxxx, xxxxx sůl [1]	11138-47-9 [1]	234-390-0 [1]
	kyselina xxxxxxxxx, xxxxx sůl, monohydrát [2]	12040-72-1 [2]	234-390-0 [2]
	kyselina xxxxxxxxx (XXX(X2)), xxxxx xxx, xxxxxxxxxx [3]	10332-33-9 [3]	231-556-4 [3]
1400	Xxxxxxxxxx-xxxxxxxxxxxxx	75113-37-0	401-040-5
1401	Xxxxxxxxxxxxxxxxxx nikelnatý	14708-14-6	238-753-4
1402	Mankozeb (XXX); mangan-N,N′-ethylenbis(dithiokarbamát), polymerní xxxxxxx se xxxxxxxxxx xxxx	8018-01-7	616-995-5
1403	Xxxxx (XXX); mangan-N,N′-ethylenbis(dithiokarbamát) (xxxxxxxxx)	12427-38-2	235-654-8
1404	Xxxxxxxxxxx (ISO); xxxxx-X-[({[(2,2-xxxxxxxx-2,3-xxxxxxx-1-xxxxxxxxxx-7-xx)xxx]xxxxxxxx} xxxxxxxxxxx)xxxxxxxx]-X-xxxxxxxxx-β-xxxxxxxx	82560-54-1	617-356-3
1405	X-xxxxxxxx-X-xxxxxx karbonylthiokarbamát	103122-66-3	434-350-4
1406	Chlorprofam (XXX); xxxxxxxxx-3-xxxxxxxxxxxxxxx	101-21-3	202-925-7
1407	Xxxxx-X-(xxxxxxxxxxxxxx)xxxxxxxxxxxx	109202-58-6	432-750-3
1408	Xxxxxxxxxxxxxxx-xxxxxx	13465-08-2	236-691-2
1409	(4-Xxxxxxxxxxx)[3-(3-xxxxxx-4-xxxxxxxxxx)xxxxxx]xxxxxxxxxxxxx	105024-66-6	405-020-7
1410	Xxxxx (XXX); xxxxxxx-X-[xxxxx(xxxx)xxxxxx]xxxxxxxxxxxx	14816-18-3	238-887-3
1411	Xxxxxxxxxx xxxxxx (XXX); xxxxxxx-2-xxxxx-4-[xxxxxxx (xxxxxx)xxxxxxxx]xxxxxxxx	77182-82-2	278-636-5
1412	Xxxxxxx xxxx: dimethyl-{2-[N-(hydroxymethyl)karbamoyl]ethyl}fosfonát; xxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxx-xxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx	—	435-960-3
1413	(4-Xxxxxxxxxx)xxxxxxxxx xxxxxxxx	86552-32-1	420-450-5
1414	Xxxxxxx xxxx: 4,7-bis(merkaptomethyl)-3,6,9-trithia-1,11-undekandithiol; 4,8-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx; 5,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx	170016-25-8	427-050-1
1415	Xxxxxxxxxxx xxxxxxxxxx-xxxxxxxxxxxxxx(X2Xx6X13)	12056-51-8	432-240-0
1416	Xxxxx xxxxxxxxxx	71-48-7	200-755-8
1417	Xxxxxxxx xxxxxxxxxx	10141-05-6	233-402-1
1418	Xxxxxxxxx xxxxxxxxxx	513-79-1	208-169-4
1419	Xxxxxxx xxxxxxxxx	7718-54-9	231-743-0
1420	Xxxxxxxx xxxxxxxxx [1]	13138-45-9 [1]	236-068-5 [1]
1420	xxxxxxxx dusičná, sůl xxxxx [2]	14216-75-2 [2]	238-076-4 [2]
1421	Xxxxxxx xxxxxxx (xxxx)	69012-50-6	273-749-6
1422	Xxxxx x kaly x xxxxxxxxxxxxxx xxxxxxxx xxxx, xxxxxxx mědi, s xxxxxxx xxxxxx nikelnatého	92129-57-2	295-859-3
1423	Bahna x xxxx x xxxxxxxxxxxxxx xxxxxxxx xxxx, xxxxxxx mědi	94551-87-8	305-433-1
1424	Chloristan nikelnatý; xxxxxxxx chloristá, nikelnatá xxx	13637-71-3	237-124-1
1425	Xxxxx xxxxxxxxxx-xxxxxxxxx [1]	13842-46-1 [1]	237-563-9 [1]
1425	xxxxx xxxxxxxx-xxxxxxxxx [2]	15699-18-0 [2]	239-793-2 [2]
1426	Xxxx-xxx(xxxxxxxxxx); xxxx-xxxxxxxx	13770-89-3	237-396-1
1427	Xxxxxxxxxxxxxxxxxx nikelnatý	14708-14-6	238-753-4
1428	Nikl-diformiát [1]	3349-06-2 [1]	222-101-0 [1]
	mravenčí xxxxxxxx, xxx xxxxx [2]	15843-02-4 [2]	239-946-6 [2]
	mravenčí xxxxxxxx, xxx mědi x xxxxx [3]	68134-59-8 [3]	268-755-0 [3]
1429	Xxxx-xxxxxxxx [1]	373-02-4 [1]	206-761-7 [1]
1429	xxxx-xxxxxx [2]	14998-37-9 [2]	239-086-1 [2]
1430	Xxxx(XX)-xxxxxxxxx	553-71-9	209-046-8
1431	Xxxx-xxx(4-xxxxxxxxxxxxxxxxxx)	3906-55-6	223-463-2
1432	Xxxx(XX)-xxxxxxx; nikl(II)-stearát	2223-95-2	218-744-1
1433	Nikl-dilaktát	16039-61-5	—
1434	Nikl(II)-oktanoát	4995-91-9	225-656-7
1435	Fluorid xxxxxxxxx [1]	10028-18-9 [1]	233-071-3 [1]
	xxxxxx xxxxxxxxx [2]	13462-88-9 [2]	236-665-0 [2]
	xxxxx xxxxxxxxx [3]	13462-90-3 [3]	236-666-6 [3]
	xxxxxxx xxxxxxxx-xxxxxxxxx [4]	11132-10-8 [4]	- [4]
1436	Xxxxxxxxxxxxxxxxxxxx xxxxxxxxx	26043-11-8	247-430-7
1437	Xxxxxxx nikelnatý	15060-62-5	239-125-2
1438	Hydrogenfosforečnan nikelnatý [1]	14332-34-4 [1]	238-278-2 [1]
	bis(dihydrogenfosforečnan) xxxxxxxxx [2]	18718-11-1 [2]	242-522-3 [2]
	xxxxxxxxxxxxxxxx nikelnatý [3]	10381-36-9 [3]	233-844-5 [3]
	xxxxxxxxxxxxx xxxxxxxxxxx [4]	14448-18-1 [4]	238-426-6 [4]
	xxx(xxxxxxxxx) xxxxxxxxx [5]	14507-36-9 [5]	238-511-8 [5]
	xxxxxxxxxxxx xxxxx [6]	36026-88-7 [6]	252-840-4 [6]
	xxxxxxxx xxxxxxxxxx, xxx vápníku a xxxxx [7]	17169-61-8 [7]	- [7]
	xxxxxxxx xxxxxxxxxxxx, xxxxxxxxx xxx [8]	19372-20-4 [8]	— [8]
1439	Xxxxxxxxxxxxxxxxxxxxx diamonno-nikelnatý	74195-78-1	—
1440	Kyanid xxxxxxxxx	557-19-7	209-160-8
1441	Xxxxxxx xxxxxxxxx	14721-18-7	238-766-5
1442	Xxxxxxxxxx xxxxxxxxx [1]	21784-78-1 [1]	244-578-4 [1]
	xxxxxxxxxxxxxxx dinikelnatý [2]	13775-54-7 [2]	237-411-1 [2]
	xxxxxxxxxx xxxxxxxxx (3:4) [3]	31748-25-1 [3]	250-788-7 [3]
	xxxxxxxx křemičitá, xxx xxxxx [4]	37321-15-6 [4]	253-461-7 [4]
	xxxxxxxxxxx-xxxxxxxxxx [xxxxxxxxxxxxx(4-)]xxxxxxxxxxxx(3-)xxxxxxxx [5]	12519-85-6 [5]	235-688-3 [5]
1443	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxx	14874-78-3	238-946-3
1444	Xxxxxxxxxxxxx xxxxxxxxxxxx; xxxxxxxxxx xxxxxxxxx	13477-70-8	236-771-7
1445	Xxxx(XX)-xxxxxx [1]	547-67-1 [1]	208-933-7 [1]
1445	xxxxxxxxx xxxxxxxx, sůl xxxxx [2]	20543-06-0 [2]	243-867-2 [2]
1446	Xxxxxxxx nikelnatý	12142-88-0	235-260-6
1447	Tetrasulfid triniklu	12137-12-1	—
1448	Bisarsenitan xxxxxxxxxxxx	74646-29-0	—
1449	Xxxx xxxxxxxx x xxxxxxx niklu a xxxxxxx; X.X. xxxxxxxxxx xxxx 25; C.I. 77332 [1]	68186-89-0 [1]	269-051-6 [1]
	xxxxxx xxxxxxxxxx-xxxxxxxxx [2]	58591-45-0 [2]	261-346-8 [2]
	oxid xxxxxxx x xxxxx [3]	12737-30-3 [3]	620-395-9 [3]
1450	Xxxxxxx xxxxxxxxx-xxxxxxxx; xxxxxxxxx xxxxxxxxx	12035-38-0	234-824-9
1451	Xxxxxxxx xxxxxxxxx-xxxxxxxxxx	15780-33-3	239-876-6
1452	Xxxxxxxxxxxxxx xxxxxxxxx	13689-92-4	237-205-1
1453	Xxxxxxxxx nikelnatý	15586-38-6	239-646-5
1454	Seleničitan xxxxxxxxx	10101-96-9	233-263-7
1455	Xxxxxxx xxxxxxxxx	1314-05-2	215-216-2
1456	Xxxxxxxx křemičitá, xxx xxxxx x xxxxx	68130-19-8	—
1457	Xxxxxxxxx xxxxx [1]	12068-61-0 [1]	235-103-1 [1]
1457	xxxxxxx xxxxx [2]	27016-75-7 [2]	248-169-1 [2]
1458	Xxxxxx žlutý xxxxxxxx x xxxxxxx xxxxx, barya x xxxxxx; C.I. xxxxxxxxxx xxxx 157; C.I. 77900	68610-24-2	271-853-6
1459	Xxxxxxxxxx xxxxxxxxx [1]	67952-43-6 [1]	267-897-0 [1]
	xxxxxxxxx xxxxxxxxx [2]	14550-87-9 [2]	238-596-1 [2]
	ethyl-hydrogen-sulfát, xxxxxxxxx xxx [3]	71720-48-4 [3]	275-897-7 [3]
1460	Xxxx(XX)-xxxxxxxxxxxxxx [1]	16083-14-0 [1]	240-235-8 [1]
	nikl(II)-propionát [2]	3349-08-4 [2]	222-102-6 [2]
	nikl-bis(benzensulfonát) [3]	39819-65-3 [3]	254-642-3 [3]
	nikl(II)-hydrogen-citrát [4]	18721-51-2 [4]	242-533-3 [4]
	xxxxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx xxx [5]	18283-82-4 [5]	242-161-1 [5]
	xxxxxxxxx kyselina, xxx xxxxx [6]	22605-92-1 [6]	245-119-0 [6]
	nikl-[bis(2-ethylhexanoát)] [7]	4454-16-4 [7]	224-699-9 [7]
	2-xxxxxxxxxxxxx xxxxxxxx, xxx xxxxx [8]	7580-31-6 [8]	231-480-1 [8]
	xxxxxxxxxxxxxxxx kyselina, xxx niklu [9]	93983-68-7 [9]	301-323-2 [9]
	xxxx(XX)-xxxxxxxxxxx [10]	29317-63-3 [10]	249-555-2 [10]
	xxxxxxxxxxx kyselina, xxx xxxxx [11]	27637-46-3 [11]	248-585-3 [11]
	xxxx-xxxxxxxxxxxxx [12]	84852-37-9 [12]	284-349-6 [12]
	xxxx(XX)-xxxxxxxxxxx [13]	93920-10-6 [13]	300-094-6 [13]
	xxxx(XX)-xxxxxxxxxxx [14]	85508-43-6 [14]	287-468-1 [14]
	xxxx(XX)-xxxxxxxxxxx [15]	85508-44-7 [15]	287-469-7 [15]
	xxxxxxxxxxx xxxxxxxx, xxx xxxxx [16]	51818-56-5 [16]	257-447-1 [16]
	xxxx(XX)-xxxxxxxxxxxxx [17]	93920-09-3 [17]	300-093-0 [17]
	xxx(X-xxxxxxxxx-X 1,O 2)xxxx [18]	71957-07-8 [18]	276-205-6 [18]
	xxxx-xxx(3,5-xx-xxxx-xxxxx-4-xxxxxxxxxxxxxx (1:2) [19]	52625-25-9 [19]	258-051-1 [19]
	xxxx(XX)-xxxxxxxx [20]	13654-40-5 [20]	237-138-8 [20]
	(2-ethylhexanoato-O)(isononanoato-O)nikl [21]	85508-45-8 [21]	287-470-2 [21]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [22]	85508-46-9 [22]	287-471-8 [22]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [23]	84852-35-7 [23]	284-347-5 [23]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [24]	84852-39-1 [24]	284-351-7 [24]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [25]	85135-77-9 [25]	285-698-7 [25]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [26]	85166-19-4 [26]	285-909-2 [26]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [27]	84852-36-8 [27]	284-348-0 [27]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [28]	85551-28-6 [28]	287-592-6 [28]
	xxxxxx kyseliny, X6-19 xxxxxxxxxx, xxxx xxxxx [29]	91697-41-5 [29]	294-302-1 [29]
	xxxxxx xxxxxxxx, X8-18 x xxxxxxxxxx X18, xxxx niklu [30]	84776-45-4 [30]	283-972-0 [30]
	xxxxxxxx-2,7-xxxxxxxxxxx xxxxxxxx, xxxxxxxxx xxx [31]	72319-19-8 [31]	[31]
1461	Xxxxxxxxx nikelnatý [1]	7757-95-1 [1]	231-827-7 [1]
	xxxxxxx nikelnato-telluričitý [2]	15851-52-2 [2]	239-967-0 [2]
	tetraoxid xxxxxxxxx-xxxxxxxxx [3]	15852-21-8 [3]	239-974-9 [3]
	xxxxxxxxxxx-xxxxxxxx-xxxx molybdenu x xxxxx [4]	68130-36-9 [4]	268-585-7 [4]
1462	Xxxxx xxxxx (NiB) [1]	12007-00-0 [1]	234-493-0 [1]
	borid xxxxxxx [2]	12007-01-1 [2]	234-494-6 [2]
	xxxxx triniklu [3]	12007-02-2 [3]	234-495-1 [3]
	xxxxx xxxxx [4]	12619-90-8 [4]	235-723-2 [4]
	silicid xxxxxxxxx [5]	12059-14-2 [5]	235-033-1 [5]
	xxxxxxxxx xxxxx [6]	12201-89-7 [6]	235-379-3 [6]
	xxxxxx diniklu [7]	12035-64-2 [7]	234-828-0 [7]
	fosfid xxxxx a xxxx [8]	65229-23-4 [8]	[8]
1463	Xxxxxxxxx xxxxxxxxx-xxxxxxxxx [1]	12004-35-2 [1]	234-454-8 [1]
	trioxid xxxxxxxxx-xxxxxxxxxx [2]	12035-39-1 [2]	234-825-4 [2]
	xxxx xxxxx a xxxxxx [3]	12653-76-8 [3]	235-752-0 [3]
	xxxxxxxx xxxxxxxxx-xxxxxxxxxxx [4]	52502-12-2 [4]	257-970-5 [4]
	oktaoxid kobaltnato-nikelnato-dimolybdenový [5]	68016-03-5 [5]	268-169-5 [5]
	xxxxxxx xxxxxxxxx-xxxxxxxxxxx [6]	70692-93-2 [6]	274-755-1 [6]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxxxx [7]	14177-55-0 [7]	238-034-5 [7]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxxx [8]	14177-51-6 [8]	238-032-4 [8]
	xxxxxx, xxxxxxx zeleň [9]	68515-84-4 [9]	271-112-7 [9]
	xxxxxx xxxxxxxx-xxxxxxxxx [10]	12031-65-1 [10]	620-400-4 [10]
	oxid xxxxxxxxx a xxxxx [11]	12673-58-4 [11]	— [11]
1464	Kobalt-lithium-nikl-oxid	—	442-750-5
1465	Oxid xxxxxxxxxxx	1313-27-5	215-204-7
1466	Xxxxxxxxxxxxxxxxxxx (XXXX)	683-18-1	211-670-0
1467	4,4′-xxx(X-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxxxxxx) xxxxxxxxxxxxx	151882-81-4	418-770-5
1468	Xxxxxxxxxxxxxxx; (2-xxxxx)xxxxxxxx	98-00-0	202-626-1
1469	1,2-Xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx; 4-xxxxxxxxxxxxxxxxxxxxxxx	106-87-6	203-437-7
1470	6-Xxxxxxxxxxxxxxx-1-xx-xxxxxxxxxxxxxxx	27610-48-6	429-960-2
1471	2-(2-Xxxxxxxxxxxxxxx)xxxxxxx (XXXX)	111-41-1	203-867-5
1472	1,2-Xxxxxxxxxxxxx	629-14-1	211-076-1
1473	(2,3-Xxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx	3033-77-0	221-221-0
1474	1-(2-Xxxxx-5-xxxxxxxxxx)-2,2,2-xxxxxxxxxxxxx-1,1-xxxx-xxxxxxxxxxxx	214353-17-0	433-580-2
1475	(X)-3-[1-[4-[2-(xxxxxxxxxxxxx)xxxxxx]xxxxx]-2-xxxxxxxx-1-xxxx]xxxxx	82413-20-5	428-010-4
1476	4,4′-[1,3-Xxxxxxxxxx(1-xxxxxxxxxxxxx)]xxxxxxx	13595-25-0	428-970-4
1477	2-Xxxxx-6-xxxxxxxxxx	2040-90-6	433-890-8
1478	5-Xxxx-xxxxx-2-xxxxxxxxxxxx-1-xxxxx	—	444-970-7
1479	2-Xxxxxxx-3-xxxxxxx-5-xxxxxxxxxxxxxx-3-xx-xxxxxxxx-2-xx-1-xx	94723-86-1	425-150-8
1480	Xxxxxxxxxx (XXX); 2-{(XX)-1-[(2XX)-2-(4-xxxxxxxxxxxx) xxxxxxxxxxxx]xxxxx}-3-xxxxxxx-5-(xxxxx-3-xx)xxxxxxxx-2-xx-1-xx	139001-49-3	604-105-8
1481	Xxxxxxxxxxxx (XXX); (XX)-(XX)-2-{1-[(2X)-3-xxxxxxxxxxxxxxxxxx]xxxxxx}-3-xxxxxxx-5-xxxxxxxxxxxxx-4-xxxxxxxxxx-2-xx-1-xx	149979-41-9	604-715-4
1482	3,3-(Xxxxxxxxxxxx)xxxxx-5(10),9(11)-xxxx-17-xx	5571-36-8	427-230-8
1483	Xxxxxxxx-1,4,9(11)-xxxxx-3,17-xxxx	15375-21-0	433-560-3
1484	Xxxxxxx xxxx: kalcium-alkylsalicyláty (xxxxxxxxxx xxxxxx X10-X14 x X18-X30); xxxxxxx-xxxxxxxxxxxxx (rozvětvené xxxxxx X10-X14 x X18-X30); kalcium-alkylbenzenthioláty (xxxxxxxxxx xxxxxx X10-X14 a X18-X30)	—	415-930-6
1485	Xxxxxxxx 1,2-xxxxxxxxxxxxxxxxxxx; xxxxxxx-(xxxxxx X6-X8)xxxxxx, xxxxxxxxxx, bohaté xx X7	71888-89-6	276-158-1
1486	Xxxxxxx xxxx: xxxxxxx 4,4′-xxxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] x xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:2); xxxxxxxx 4,4′-methylenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenolu] x xxxxxxxx 6-diazo-5,6-dihydro-5-oxonaftalen-1-sulfonové (1:3)	—	427-140-9
1487	Xxxxxxxxx 1-xxxxxxx-2-(4-(4-xxxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx)-7-xxxxx-3-xxxxxxxxxxxxxxxx	150202-11-2	422-670-7
1488	Xxxxxxxx 3-xxxxxxxxxx-4-xx-17-β -karboxylová	302-97-6	414-990-0
1489	Kyselina (X)-2-xxxxxxxxxxx-2-[2-(xxxxxxxxxxx)xxxxxxx-4-xx]xxxxxx	64485-90-1	431-520-1
1490	Xxxxxxxxxx-xxxxxxxxxxxxxxxx	5064-31-3	225-768-6
1491	2-Xxxxxxxxxx-(2-xxxxxxxxxxxxx)	7425-14-1	231-057-1
1492	Xxxxxxxxxx-xxxxxx	84-69-5	201-553-2
1493	Xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx; xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxx xxxxxxxx [1]	1763-23-1 [1]	217-179-8 [1]
	xxxxxx-xxxxxxxxxxxxxxxxxxxxx; xxxxxx-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxx [2]	2795-39-3 [2]	220-527-1 [2]
	xxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]	70225-14-8 [3]	274-460-8 [3]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx; amonium-heptadekafluoroktansulfonát [4]	29081-56-9 [4]	249-415-0 [4]
	lithium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [5]	29457-72-5 [5]	249-644-6 [5]
1494	Xxxxx-[1-(2,4-xxxxxxxxxxxx)5-(xxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx]	103112-35-2	401-290-5
1495	1-Xxxx-2-xxxxxxxxxxxxxxxxxxxxx	158894-67-8	422-900-6
1496	1-Xxxxxxxxxxxxxxx-xxxxxxxxxxxxx	99464-83-2	444-950-8
1497	6,6′-Xxx(xxxxx-5,5′,6,6′-xxxxxxxxxx-5,5′-xxxxx)[xxxxxxxxxxx(5-(6-xxxxx-5,6-xxxxxxx-5-xxx-1-xxxxxxxxxxxxxxxxx)-6-xxxxxx-2-xxxxxxx]xx(xxxxxxxx-1-xxxxxxxx)	—	441-550-5
1498	Xxxxxxxxxxx (ISO); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidin; 2,6-xxxxxxx-X,X-xxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx; X,X-xxxxxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx	1582-09-8	216-428-8
1499	4-Xxxxx-2-xxxxxxxxxxx	1671-49-4	430-550-0
1500	Xxxxxxxxxx-4-[(4-[1-xxxxxxx-7-(4-xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxx-2-xxxxxx]xxx-2,5-xxxxxxxxxxxxxx)xxx]xxxxxxx	221354-37-6	432-270-4
1501	Xxxxxxx xxxx: xxxxxxxxxx-6-xxxxx-3-({2,5-xxxxxxxx-4-[(3-xxxxxxxxxxxx)xxx]xxxxx}xxx)-4-xxxxxxxxxxxxxxx-2-xxxxxxxx; xxxxxxxxx-3-({4-[(7-xxxxx-1-xxxxxxx-3-xxxxx-2-xxxxxx)xxx]-2,5-xxxxxxxxxxxxx}xxx)xxxxxxx	163879-69-4	438-310-7
1502	X,X′-(xxxxxxx-4,4′-xxxx)xxxxxxxxxxx	613-35-4	210-338-2
1503	Xxxxxxxxxxxxxx	108-91-8	203-629-0
1504	Xxxxxxxxx	110-85-0	203-808-3
1505	Xxxxxxxxxxxx	7803-49-8	232-259-2
1506	Xxxxxxxxxxxxxxx-xxxxxxx; hydroxylamin-hydrochlorid [1]	5470-11-1 [1]	226-798-2 [1]
1506	xxx(xxxxxxxxxxxxxxx-xxxxxx); xxxxxxxxxxxx-xxxxxx (2:1) [2]	10039-54-0 [2]	233-118-8 [2]
1507	Xxxxxxxxxxxxxxxxxxx; xxxxxxxxxxxxx	—	—
1508	Xxxxxxxxxxx; 4-xxxxxx-X-xxxxx-6-(1-xxxxxxxx)-2-xxxxxxxxxxxxx	110235-47-7	600-951-7
1509	Xxxxxxxxxxxxxxx-xxxxxxxxxxxxxx; xxxxxxxxxxxx-xxxxxx (1:1) [1]	10046-00-1 [1]	233-154-4 [1]
	xxxxxxxxxxxx-xxxxxx [2]	20845-01-6 [2]	244-077-0 [2]
	hydroxylamin-dihydrogenfosfát [3]	19098-16-9 [3]	242-818-2 [3]
	xxxxxxxxxxxx-4-xxxxxxxxxxxx-1-xxxxxxxx [4]	53933-48-5 [4]	258-872-5 [4]
1510	(3-Xxxxx-2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx	3327-22-8	222-048-3
1511	Xxxxxxx-3,3′,4,4′-xxxxxxxx; 3,3′-xxxxxxxxxxxxxxx	91-95-2	202-110-6
1512	Xxxxxxxxx-xxxxxxxxxxxx [1]	6094-40-2 [1]	228-042-7 [1]
	xxxxxxxxx-xxxxxxxxxxxxxx [2]	142-64-3 [2]	205-551-2 [2]
	xxxxxxxxx-xxxxxx [3]	1951-97-9 [3]	217-775-8 [3]
1513	3-(Xxxxxxxxx-1-xx)-xxxxx[x]xxxxxxxxxx-xxxxxxxxxxxx	87691-88-1	421-310-6
1514	(2-Xxxxxxxxxx)xxxxxxxx-xxxxxxxxxxxx	19398-06-2	421-460-2
1515	(2-Xxxxxxxxxx)(3-xxxxxxxxxxxxx)xxxxxxx-xxxxxxx	40722-80-3	429-740-6
1516	4-[(3-Xxxxxxxxxx)(xxxxxxxx-1-xx)xxxxxx]xxxxxx-1,2-xxxxxxxxxxxxxxxxxxxx	159939-85-2	425-030-5
1517	Xxxxx-X,X-xxxxxxxxxxxxxxxxxxx-xxxxxxx	3724-43-4	425-970-6
1518	7-Xxxxxxx-6-[3-(xxxxxxxx-4-xx)xxxxxxx]xxxxxxxxxx-4(3X)-xx;	199327-61-2	429-400-7
1519	Xxxxxxxx xxxxxx xxx(2-xxxxxxxxxxxxx) xxxxx s xxxxxxxxxxxxx (1:4)	220444-73-5	432-440-8
1520	3-Xxxxx-4-[(3-xxxxxxxxxxx)xxx]xxxxxx	202197-26-0	445-590-4
1521	Xxxxxxxxxxxxxx; 3,8-Xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx	1239-45-8	214-984-6
1522	(2XX)-2-xxxxx-3,3-xxxxxxxxxxxxxxxxx	144177-62-8	447-860-7
1523	9-Xxxxxxxxxxxxx-3-xxxx; (9-Xxxxxxxxxxxxx-3-xx)xxxx	132-32-1	205-057-7
1524	(6X-xxxxx)-1-((7-xxxxxx-2-xxxxxxxxxxx-8-xxx-5-xxxx-1-xxxxxxxxxx-[4.2.0]xxx-2-xx-3-xx)xxxxxx)xxxxxxxxxx-xxxxx	100988-63-4	423-260-0
1525	Xxxxxxxxxxxxxxx (XXX); 1-(2-chlor-4-pyridyl)-3-fenylmočovina	68157-60-8	614-346-0
1526	1,3-Dimethyltetrahydropyrimidin-2(1H)-on; dimethylpropylenmočovina	7226-23-5	230-625-6
1527	Chinolin	91-22-5	202-051-6
1528	Ketokonazol; 1-[4-(4-{[(2XX,4XX)-2-(2,4-xxxxxxxxxxxx)-2-(xxxxxxxx-1-xxxxxxxx)-1,3-xxxxxxxx-4-xx]xxxxxxx} xxxxx)xxxxxxxxx-1-xx]xxxxx-1-xx	65277-42-1	265-667-4
1529	Xxxxxxxxxx (XXX); (1XX,5XX;1XX,5XX)-5-(4-xxxxxxxxxxx)-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx	125116-23-6	603-031-3
1530	Xxxxxx-1-xxxxxx-4-{3-[1-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-5-xxx-4,5-xxxxxxxxxxxxxx-4-xxxxxx]xxxx-1-xx-1-xx}-3-(xxxxxxxxxxxxxxxxx)xxxxxxx-5-xxxx	183196-57-8	418-260-2
1531	1,3,5-Xxxx(2,3-xxxxx-2-xxxxxxxxxxxx)-1,3,5-xxxxxxx-2,4,6(1X,3X,5X)-xxxxx	26157-73-3	435-010-8
1532	2,2-Xxx(xxxxxxxxxxxxx)xxxxx-1-xx-xxxx[3-(xxxxxxxx-1-xx)xxxxxxxxx]; (XXX)	52234-82-9	257-765-0
1533	4,4′-Xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-4,4′-xxxxxxxxxxx [1]	101-68-8 [1]	202-966-0 [1]
	2,2′-xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-2,2′-xxxxxxxxxxx [2]	2536-05-2 [2]	219-799-4 [2]
	o-(p-isocyanatobenzyl)fenyl xxxxxxxxx; xxxxxxxxxxxxx-2,4′-xxxxxxxxxxx [3]	5873-54-1 [3]	227-534-9 [3]
	xxxxxxxxxxxxxxx-xxxxxxxxxxx [4]	26447-40-5 [4]	247-714-0 [4]
1534	Xxxxxxx xxxxx (XXX); xxxxx-(X)-2-xxxxx-3-[2-xxxxx-5-(xxxxxxxx-1-xx-1,2-xxxxxxxxxxxxx)xxxxx]xxxxxxx	142891-20-1	604-318-6
1535	X-[6,9-xxxxxxx-9-[[2-xxxxxxx-1-(xxxxxxxxxxxxx)xxxxxx]xxxxxx]-6-xxx-1X-xxxxx-2-xx]xxxxxxxx	84245-12-5	424-550-1
1536	Xxxxxxxxxxxxx (XXX); (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx	149961-52-4	604-712-8
1537	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxx	27366-72-9	435-470-1
1538	Xxxxxxx xxxx: 2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx[X-(2,4-xxxxxxxxxxxxx)-3-xxxxxxxxxxxx]; X-(2,4-xxxxxxxxxxxxx)-X′-(2-xxxxxxxxxxx)-2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx(3-xxxxxxxxxxxx); 2-[[3,3′-xxxxxxx-4′-[[1[[(2,4-xxxxxxxxxxxxx)xxxxx]xxxxxxxx]-2-xxxxxxxxx]xxx][1,1′-xxxxxxx]-4-xx]xxx]-X-(2-xxxxxxxxxxxxx)-3-xxx-xxxxxxxxx		434-330-5
1539	Xxxx, uhlí, xxxxx x xxxxx xxxx x jejich xxxxxxxx generované xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx metod zpracování, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxxxxx	85536-20-5 85536-19-2 90641-12-6 90989-38-1 91995-20-9 92062-36-7 91995-61-8 101316-63-6 93821-38-6 90641-02-4 101316-62-5 90641-03-5 65996-79-4 101794-90-5 90640-87-2 84650-03-3 65996-82-9 90641-01-3 65996-87-4 90640-99-6 68391-11-7 92062-33-4 91082-52-9 68937-63-3 92062-28-7 92062-27-6 91082-53-0 91995-31-2 91995-35-6 91995-66-3 122070-79-5 122070-80-8 65996-78-3 94114-52-0 94114-53-1 94114-54-2 94114-56-4 94114-57-5 90641-11-5 8006-61-9 8030-30-6 8032-32-4 64741-41-9 64741-42-0 64741-46-4 64742-89-8 68410-05-9 68514-15-8 68606-11-1 68783-12-0 68921-08-4 101631-20-3 64741-64-6 64741-65-7 64741-66-8 64741-70-4 64741-84-0 64741-92-0 68410-71-9 68425-35-4 68527-27-5 91995-53-8 92045-49-3 92045-55-1 92045-58-4 92045-64-2 101316-67-0 64741-54-4 64741-55-5 68476-46-0 68783-09-5 91995-50-5 92045-50-6 92045-59-5 92128-94-4 101794-97-2 101896-28-0 64741-63-5 64741-68-0 68475-79-6 68476-47-1 68478-15-9 68513-03-1 68513-63-3 68514-79-4 68919-37-9 68955-35-1 85116-58-1 91995-18-5 93571-75-6 93572-29-3 93572-35-1 93572-36-2 64741-74-8 64741-83-9 67891-79-6 67891-80-9 68425-29-6 68475-70-7 68603-00-9 68603-01-0 68603-03-2 68955-29-3 92045-65-3 64742-48-9 64742-49-0 64742-73-0 68410-96-8 68410-97-9 68410-98-0 68512-78-7 85116-60-5 85116-61-6 92045-51-7 92045-52-8 92045-57-3 92045-61-9 92062-15-2 93165-55-0 93763-33-8 93763-34-9 64741-47-5 64741-48-6 64741-69-1 64741-78-2 64741-87-3 64742-15-0 64742-22-9 64742-23-0 64742-66-1 64742-83-2 64742-95-6 68131-49-7 68477-34-9 68477-50-9 68477-53-2 68477-55-4 68477-61-2 68477-89-4 68478-12-6 68478-16-0 68513-02-0 68516-20-1 68527-21-9 68527-22-0 68527-23-1 68527-26-4 68603-08-7 68606-10-0 68783-66-4 68919-39-1 68921-09-5 85116-59-2 86290-81-5 90989-42-7 91995-38-9 91995-41-4 91995-68-5 92045-53-9 92045-60-8 92045-62-0 92045-63-1 92201-97-3 93165-19-6 94114-03-1 95009-23-7 97926-43-7 98219-46-6 98219-47-7 101316-56-7 101316-66-9 101316-76-1 101795-01-1 102110-14-5 68476-50-6 68476-55-1 90989-39-2	287-502-5 287-500-4 292-636-2 292-694-9 295-281-1 295-551-9 295-323-9 309-868-8 298-725-2 292-625-2 309-867-2 292-626-8 266-013-0 309-971-8 292-609-5 283-483-2 266-016-7 292-624-7 266-021-4 292-622-6 269-929-9 295-548-2 293-766-2 273-077-3 295-543-5 295-541-4 293-767-8 295-292-1 295-295-8 295-329-1 310-170-0 310-171-6 266-012-5 302-688-0 302-689-6 302-690-1 302-692-2 302-693-8 292-635-7 232-349-1 232-443-2 232-453-7 265-041-0 265-042-6 265-046-8 265-192-2 270-077-5 271-025-4 271-727-0 272-186-3 272-931-2 309-945-6 265-066-7 265-067-2 265-068-8 265-073-5 265-086-6 265-095-5 270-088-5 270-349-3 271-267-0 295-315-5 295-430-0 295-436-3 295-440-5 295-446-8 309-871-4 265-055-7 265-056-2 270-686-6 272-185-8 295-311-3 295-431-6 295-441-0 295-794-0 309-974-4 309-987-5 265-065-1 265-070-9 270-660-4 270-687-1 270-794-3 270-993-5 271-008-1 271-058-4 272-895-8 273-271-8 285-509-8 295-279-0 297-401-8 297-458-9 297-465-7 297-466-2 265-075-6 265-085-0 267-563-4 267-565-5 270-344-6 270-658-3 271-631-9 271-632-4 271-634-5 273-266-0 295-447-3 265-150-3 265-151-9 265-178-6 270-092-7 270-093-2 270-094-8 270-988-8 285-511-9 285-512-4 295-432-1 295-433-7 295-438-4 295-443-1 295-529-9 296-942-7 297-852-0 297-853-6 265-047-3 265-048-9 265-071-4 265-079-8 265-089-2 265-115-2 265-122-0 265-123-6 265-170-2 265-187-5 265-199-0 268-618-5 270-725-7 270-735-1 270-736-7 270-738-8 270-741-4 270-771-8 270-791-7 270-795-9 270-991-4 271-138-9 271-262-3 271-263-9 271-264-4 271-266-5 271-635-0 271-726-5 272-206-0 272-896-3 272-932-8 285-510-3 289-220-8 292-698-0 295-298-4 295-302-4 295-331-2 295-434-2 295-442-6 295-444-7 295-445-2 296-028-8 296-903-4 302-639-3 305-750-5 308-261-5 308-713-1 308-714-7 309-862-5 309-870-9 309-879-8 309-976-5 310-012-0 270-690-8 270-695-5 292-695-4
1540	Xxxx, uhlí, xxxxx x xxxxx xxxx x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx jiných xxxxx xxxxxxxxxx, pokud xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx
		90640-85-0 92061-93-3 90640-84-9 61789-28-4 70321-79-8 122384-77-4 70321-80-1	292-606-9 295-506-3 292-605-3 263-047-8 274-565-9 310-189-4 274-566-4
1541	Xxxx, xxxx, xxxxx a xxxxx xxxx x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx obsahují ≥ 0,1 % xxxxxxxxxxxx benzenu xxxx xxxxx xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx
		85029-51-2 84650-04-4 84989-09-3 91995-49-2 121620-47-1 121620-48-2 90640-90-7 90641-04-6 101896-27-9 101794-91-6 91995-48-1 90641-05-7 84989-12-8 121620-46-0 90640-81-6 90640-82-7 92061-92-2 91995-15-2 91995-16-3 91995-17-4 101316-87-4 122384-78-5 84988-93-2 90640-88-3 65996-83-0 90640-89-4 90641-06-8 65996-85-2 101316-86-3 92062-22-1 96690-55-0 84989-04-8 84989-05-9 84989-06-0 84989-03-7 84989-07-1 68477-23-6 68555-24-8 91079-47-9 92062-26-5 94114-29-1 90641-00-2 68513-87-1 70321-67-4 92062-29-8 100801-63-6 100801-65-8 100801-66-9 73665-18-6 68815-21-4 65996-86-3 65996-84-1	285-076-5 283-484-8 284-898-1 295-310-8 310-166-9 310-167-4 292-612-1 292-627-3 309-985-4 309-972-3 295-309-2 292-628-9 284-901-6 310-165-3 292-603-2 292-604-8 295-505-8 295-275-9 295-276-4 295-278-5 309-889-2 310-191-5 284-881-9 292-610-0 266-017-2 292-611-6 292-629-4 266-019-3 309-888-7 295-536-7 306-251-5 284-892-9 284-893-4 284-895-5 284-891-3 284-896-0 270-713-1 271-418-0 293-435-2 295-540-9 302-662-9 292-623-1 271-020-7 274-560-1 295-544-0 309-745-9 309-748-5 309-749-0 277-567-8 272-361-4 266-020-9 266-018-8
1542	Xxxx, xxxx, xxxxx x zemní plyn x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxx-1,3-xxxxx
		68607-11-4 68783-06-2 68814-67-5 68814-90-4 68911-58-0 68911-59-1 68919-01-7 68919-02-8 68919-03-9 68919-04-0 68919-07-3 68919-08-4 68919-11-9 68919-12-0 68952-79-4 68952-80-7 68955-33-9 68989-88-8 92045-15-3 92045-16-4 92045-17-5 92045-18-6 92045-19-7 92045-20-0 68131-75-9 68307-98-2 68307-99-3 68308-00-9 68308-01-0 68308-10-1 68308-03-2 68308-04-3 68308-05-4 68308-06-5 68308-07-6 68308-09-8 68308-11-2 68308-12-3 68409-99-4 68475-57-0 68475-58-1 68475-59-2 68475-60-5 68476-26-6 68476-29-9 68476-40-4 68476-42-6 68476-49-3 68476-85-7 68476-86-8 68477-33-8 68477-35-0 68477-69-0 68477-70-3 68477-71-4 68477-72-5 68308-08-7	271-750-6 272-182-1 272-338-9 272-343-6 272-775-5 272-776-0 272-873-8 272-874-3 272-875-9 272-876-4 272-880-6 272-881-1 272-884-8 272-885-3 273-173-5 273-174-0 273-269-7 273-563-5 295-397-2 295-398-8 295-399-3 295-400-7 295-401-2 295-402-8 268-629-5 269-617-2 269-618-8 269-619-3 269-620-9 269-630-3 269-623-5 269-624-0 269-625-6 269-626-1 269-627-7 269-629-8 269-631-9 269-632-4 270-071-2 270-651-5 270-652-0 270-653-6 270-654-1 270-667-2 270-670-9 270-681-9 270-682-4 270-689-2 270-704-2 270-705-8 270-724-1 270-726-2 270-750-3 270-751-9 270-752-4 270-754-5 269-628-2
1543	Xxxx[2-xxxxx-1-(xxxxxxxxxxx)xxxxx]xxxxxx	13674-87-8	237-159-2
1544	Xxxxxx xxxxx	22398-80-7	244-959-5
1545	Xxxxxxxx-xxxxxx	25155-23-1	246-677-8
1546	Xxxxxxxxxxxxxxxxxxxx [1]	25637-99-4 [1]	247-148-4 [1]
1546	1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxx [2]	3194-55-6 [2]	221-695-9 [2]
1547	Xxxxxxxxxxxxxxx	109-99-9	203-726-8
1548	Xxxxxxxxx (xxxx xxxxxxxxxxx X1x a xxxxxxxxxxx X1x) (XXX) [1]	71751-41-2 [1]	615-339-5 [1]
1548	avermektin B1a [2]	65195-55-3 [2]	265-610-3 [2]
1549	4-Xxxx-xxxxxxxxxxxxx xxxxxxxx	98-73-7	202-696-3
1550	Xxxxxxxxxxxxxxxx xxxxx; N,N,N′,N′-tetramethyl-4,4′-benzylidendianilin	129-73-7	204-961-9
1551	Fuberidazol (XXX); 2-(2-furyl)benzimidazol	3878-19-1	223-404-0
1552	Metazachlor (ISO); 2-xxxxx-X-(2,6-xxxxxxxxxxxxx)-X-(xxxxxxx-1-xxxxxxxx)xxxxxxxx	67129-08-2	266-583-0
1553	Xx-xxxx-xxxxxxxxxxxx	110-05-4	203-733-6
1554	Xxxxxxxxxxxxxxxxxxxxx	993-16-8	213-608-8
1555	2-Xxxxxxxxxx-10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx	57583-34-3	260-828-5
1556	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	15571-58-1	239-622-4
1557	Xxxxxxxxxx (XXX); 2-[2-xxxxx-4-(xxxxxxxxxxxxxx)xxxxxxx]xxxxxxxxxx-1,3-xxxx	99105-77-8	619-394-6
1558	Xxxxxxxxxx (XXX); (2-xxxxxxxxxxxxx-3-xx)xxxxxx-xxx-(1X,3X)-3-[(1X)-2-xxxxx-3,3,3-xxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxx-xxxxxxxxxx	82657-04-3	617-373-6
1559	Xxxxxxx-xxxxxx	84-75-3	201-559-5
1560	Xxxxxxx-xxxxxxxxxxxxxxxxxxxxxx	3825-26-1	223-320-4
1561	Xxxxxxxxxxxxxxxx xxxxxxxx	335-67-1	206-397-9
1562	X-xxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxx-2-xx	2687-91-4	220-250-6
1563	Xxxxxxxxxxx (ISO); 6-xxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xx	189278-12-4	606-168-7
1564	Xxxxxxx xxxxx	1303-00-0	215-114-8
1565	Xxxxx-xxxxxx	108-05-4	203-545-4
1566	Xxxxxxxxx (XXX); 2-xxxxx-3-xxxxxx-6-xxxxxxxxxxx	74070-46-5	277-704-1
1567	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	57583-35-4	260-829-0
1568	Xxxxxxxxxxxxxxx-xxxxxxxxx	753-73-1	212-039-2
1569	4-Xxxxxxxxxxxxxxx	100-40-3	202-848-9
1570	Xxxxxxxxxxx (XXX); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyklohex-2-en-1-on	87820-88-0	618-075-9
1571	Cykloxydim (XXX); 2-(X-xxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-(xxxxxxxxxx-2X-xxxxxxxxx-3-xx)xxxxxxxx-2-xx-1-xx	101205-02-1	405-230-9
1572	Xxxxxxxxx (ISO); 3-xxxxx-X-[3-xxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxx]-5-(xxxxxxxxxxxxxx)xxxxxxx-2-xxxx	79622-59-6	616-712-5
1573	Xxxxxxxxxx (XXX); 1-[2-(2,4-dichlorfenyl)pentyl]-1H-1,2,4-triazol	66246-88-6	266-275-6
1574	Fenoxykarb (XXX); xxxxx-X-[2-(4-xxxxxxxxxxxx)xxxxx]xxxxxxxx	72490-01-8	276-696-7
1575	Xxxxxx	100-42-5	202-851-5
1576	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxx; tetrahydrofurfurylalkohol	97-99-4	202-625-6
1577	Formaldehyd	50-00-0	200-001-8
1578	Paraformaldehyd	30525-89-4	608-494-5
1579	Methandiol, xxxxxxxxxxxxxx	463-57-0	207-339-5
1580	Xxxxxxxxx (XXX); 1-ethyl-3-[2-kyan-2-(methoxyimino)acetyl]močovina	57966-95-7	261-043-0
1581	Tributylstannan, sloučeniny	—	—
1582	Tembotrion (XXX); 2-{2-xxxxx-4-(xxxxxxxxxxxxxx)-3-[(2,2,2-xxxxxxxxxxxxxx)xxxxxx]xxxxxxx}xxxxxxxxxx-1,3-xxxx	335104-84-2	608-879-8
1583	1,2-Xxxxxxxxxxxxxxxxxxx kyselina, xxxxxxxxxxxx, xxxxxxxxxx x xxxxxxxx	68515-50-4	271-093-5
1584	Xxxxxxxxxxxxx (XXX); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx	203313-25-1	606-523-6
1585	Xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx	31717-87-0	250-778-2
1586	Xxxxxxxxxxxxxx-xxxxxx; xxxxxx-2-([4-(xxxxxxxxxxxxx)-6-(2,2,2-xxxxxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxxxxxx	126535-15-7	603-146-9
1587	Xxxxxxxx (ISO); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx	35554-44-0	252-615-0
1588	Xxxxxxxx (XXX); 4-xxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx	1593-77-7	216-474-9
1589	Xxxxxxxx	288-32-4	206-019-2
1590	Xxxxxxx (XXX); 3-xxxxxxxxxx-6,7-xxxxxxx-1X-xxxxxxxxxx[x]xxxxxxxxx-2,4(3X,5X)-xxxx	2164-08-1	218-499-0
1591	Xxxxxxxxx (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx	139528-85-1	604-145-6
1592	2-Xxxxxx-1-(4-xxxxxxxxxxxxxxx)-2-xxxxxxxxxxxxxxx 1-xx	71868-10-5	400-600-6
1593	2,3-Xxxxxxxxxxx-xxxxxxxxxxx	106-91-2	203-441-9
1594	Xxxxxxxxxx (ISO) 8-xxxx-xxxxx-1,4-xxxxxxxxxx[4.5]xxxxx-2-xxxxxxxx(xxxxx)(xxxxxx)xxxx	118134-30-8	601-505-4
1595	Xxxxxxxx; karbonitril	420-04-2	206-992-3
1596	Cyprokonazol (XXX); (2XX,3XX;2XX,3XX)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx	94361-06-5	619-020-1
1597	Xxxxxxxx-xxxxxxxxx xxxxxx	130328-20-0	603-404-0
1598	Xxxxxxxxx xxxxxxxxx	513-78-0	208-168-9
1599	Xxxxxxxx xxxxxxxxx	21041-95-2	244-168-5
1600	Xxxxxxxx xxxxxxxxx	10325-94-7	233-710-6
1601	Xxxxxxxxxx-xxxxxxxx xxxxxxx[xxx(xxxxxxxxxxxxx)]xxxxxxx	77-58-7	201-039-8
1602	Xxxxxxxxx; 2-xxxxxx-4-xxxxxxxxxx	120-32-1	204-385-8
1603	Xxxxxxxxxxxx	84-65-1	201-549-0
1604	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx [1]	335-76-2 [1]	206-400-3[1]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx [2]	3108-42-7 [2]	221-470-5 [2] [3]
	sodium-nonadekafluordekanoát [3]	3830-45-3 [3]
1605	X,X′-xxxxxxxxxxxxxxxxxx; X,X′-xxxxxxxxxxxxxxxxxxx; [formaldehyd xxxxxxxx x X,X′-xxxxxxxxxxxxxxxxxxxxx]; [XXX] xxxxx maximální xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx formaldehydu xxx xxxxxx na xxxxx je ve xxxxx, xxx xx xxxxxxx xx trh, ≥ 0,1 % xxxxxxxxxxxx	5625-90-1	227-062-3
1606	Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-hydroxypropylaminem (3:2); [formaldehyd xxxxxxxx x 3,3′-xxxxxxxxxxx [5–xxxxxxxxxxxxxxxxx]; [xxxxxxxxxxx uvolněný x xxxxxxxxxxx]; [XXX], xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx uvolnitelného xxxxxxxxxxxx xxx ohledu xx xxxxx je ve xxxxx, xxx xx xxxxxxx xx trh, ≥ 0,1 % xxxxxxxxxxxx	—	—
1607	Xxxxxxx produkty xxxxxxxxxxxxxxxx x 2-xxxxxxxxxxxxxxxxxxx (1:1); [formaldehyd xxxxxxxx x α,α,α-trimethyl-1,3,5-triazin-1,3,5 (2X,4X,6X)-xxxxxxxxxxx]; [XXX], xxxxx xxxxxxxxx xxxxxxxxxx koncentrace xxxxxxxxxxxxx formaldehydu bez xxxxxx xx xxxxx xx xx xxxxx, xxx xx xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx	—	—
1608	Xxxxxxxxxxxxxx	60-34-4	200-471-4
1609	Xxxxxxxxxxx (XXX); (1XX,2XX;1XX,2XX)-1-(4-xxxxxxxxxxx)-3,3-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx); α-xxxx-xxxxx-β-(4-xxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-1-xxxxxxx	55219-65-3	259-537-6
1610	Xxxxxxxxxxx (XXX); (X)-3-(6-xxxxx-3-xxxxxxxxxxxxx)-1-3-xxxxxxxxxxx-2-xxxxxxxxxxxxxx; {(2X)-3-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-1,3-xxxxxxxxxxx-2-xxxxxx}xxxxxxxx	111988-49-9	601-147-9
1611	Xxxxxxxxxx (XXX); (X)-1-(xxxxxxxxxxxxxx)xxxxxxxxxxxxxxx (2X)-1-(xxxxxxxxxx)-1-xxxxxxxxx-2-xx-xxxxxxxxxxxxx	16118-49-3	240-286-6“

xxxxxxx 395 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx číslo

Identifikace xxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx XXX

Xxxxx XX

„395

Xxxxxxxx-8-xx x jeho xxxxxx

148-24-2

134-31-6

205-711-1

205-137-1“

2)&xxxx;&xxxx;&xxxx;

Xxxxxxx XXX xx xxxx xxxxx:

x)	xxxxxxx 1x, 1x, 7, 13 x&xxxx;51 xx xxxxxxx;

xxxxxxx 12 xx nahrazuje tímto:

Referenční xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxx

Xxxxx xxxxxxxx xxxxxxx x upozornění

Chemický xxxxx/XXX

Xxxxx v xxxxxxx xxxxxx podle xxxxxxxx xxxxxxxxxxxx

Xxxxx XXX

Xxxxx ES

Druh xxxxxxx, xxxxx xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx x xxxxxxx

Xxxx

„12

Xxxxxxx xxxxxx x xxxxxxx xxxxxxxxxx xxxx xxxxx, xxxxx xxxxxxx xxxxxx xxxxxxxx, xxxxxx látek xxxxxxxx xxxxxxx x xxxxxxx zinečnatý, x xxxxxxxx těchto xxxxx x xxxxxxx II:

—	č. 1397, 1398, 1399

Xxxxxxxx xxxxxxxx

7722-84-1

231-765-0

x)	Xxxxxxxxx na xxxxx

x)	12 % H2O2 (40 xxxxxx), xxxxxxxxxx nebo xxxxxxxxxx

x) f) Používejte xxxxxx rukavice.

a) x) x) x)

Xxxxxxxx xxxxxxx xxxxxx.

Xxxxxxxx xxxxx s xxxxx.

Xxx xxxxxxxx xxx xxxxxxxx xxxxxxxxxxx vodou.

b)	Přípravky xx xxxx

x)	4 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxxxxxxxx xxx xxxxxxx xxxxx

x)	2 % H2O2, xxxxxxxxxx nebo xxxxxxxxxx

x)	Xxxxxxxxx xxx xxxxx xxxxxxx, xxxxxx xxxxx xxxx, xxxxx xxxxx a xxxxxxxxx na xxxxxx xxxx xxxxxxxxxx xxxx

x)	≤ 0,1 % X2X2, xxxxxxxxxx nebo xxxxxxxxxx

x)	Xxxxxxxxx xx xxxxxx nebo xxxxxxxxxx zubů

e)	> 0,1 % ≤ 6 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

X prodeji xxxxx xxxxxx lékařům. X každého cyklu xxxxxxx xxxx xxx xxxxx použití provedeno xxxxxx xxxxxxx xx xxxxxx směrnice Xxxxxxxxxx xxxxxxxxxx x Xxxx 2005/36/XX&xxxx;(*1) nebo xxx xxxx přímým xxxxxxxx, xxxxx xx zaručena xxxxxxxxxx úroveň bezpečnosti.

Poté xxxxxx xxxxxxxxxxxx k xxxxxxxxx cyklu xxxxxxx.

Xxxxxxxxxx x osob mladších 18 let.

Koncentrace X2X2 xxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx x procentech.

Nepoužívat x xxxx mladších 18 xxx.

X prodeji xxxxx xxxxxx lékařům. X xxxxxxx cyklu xxxxxxx musí xxx xxxxx použití xxxxxxxxx xxxxx xxxxxx xxxxxxx xxxx xxx xxxx xxxxxx xxxxxxxx, xxxxx xx xxxxxxxx xxxxxxxxxx xxxxxx bezpečnosti.

Poté xxxxxx xxxxxxxxxxxx k xxxxxxxxx xxxxx xxxxxxx.

x)	Xxxxxxxxx určené xxx řasy

f)	2 % X2X2, přítomného xxxx xxxxxxxxxx

x)	Xxx xxx profesionální xxxxxxx.

Xx xxxxxxx xx xxxxx:

„Xxx xxx xxxxxxxxxxxxx xxxxxxx.

Xxxxxxxx xxxxx x xxxxx.

Xxx xxxxxxxx xxx xxxxxxxx vypláchněte vodou.

Obsahuje xxxxxxx vodíku.“

doplňují xx xxxx xxxxxxx, xxxxx xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx látky				Omezení			Znění xxxxxxxx použití a xxxxxxxxxx
Xxxxxxxxxx xxxxx	Xxxxxxxx xxxxx/ XXX	Xxxxx x xxxxxxx xxxxxx podle xxxxxxxx xxxxxxxxxxxx	Xxxxx XXX	Xxxxx XX	Xxxx xxxxxxx, xxxxx xxxx	Xxxxxxxx xxxxxxxxxxx v xxxxxxxxx xxxxxxxxxxx x xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„311	Xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx	Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx	75980-60-8	278-355-8	Xxxxxxx xxxxxxx xxxxx	5,0 %	Xxxxxxxxxxxxx xxxxxxx	Xxx xxx xxxxxxxxxxxxx xxxxxxx. Xxxxxxxx xxxxx x xxxx. Xxxxx pečlivě xxxxx x xxxxxxx.
312	2-Xxxxxxxxxx	Xxxxxxxx	98-01-1	202-627-7		0,001 %“

3)&xxxx;&xxxx;&xxxx;

Xxxxxxx X&xxxx;xx mění xxxxx:

x&xxxx;xxxxx se xxx 2 xxxxxxxxx tímto:

„2.	Veškeré xxxxxxx xxxxxxx xxxxxxxxxx xxxxx uvedené x&xxxx;xxxx xxxxxxx, x&xxxx;xxxxx xx xxxxxxxx xxxxxxxxxxx, musí xxx xxxxxxxx xxxxxxxxxxx „xxxxxxxx xxxxxxxxxxx“, xxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx v konečném xxxxxxx překročí 0,05 %.“;

b)	položky 5, 31, 40 x&xxxx;41 xx xxxxxxx;

xxxxxxx 28 se xxxxxxxxx xxxxx:

Xxxxxxxxxx číslo	Identifikace xxxxx				Xxxxxxxx			Xxxxx xxxxxxxx xxxxxxx x xxxxxxxxxx
Xxxxxxxxxx číslo	Xxxxxxxx xxxxx/XXX	Xxxxx v xxxxxxx xxxxxx xxxxx xxxxxxxx nomenklatury	Číslo XXX	Xxxxx XX	Xxxx xxxxxxx, xxxxx xxxx	Xxxxxxxx xxxxxxxxxxx v xxxxxxxxx xxxxxxxxxxx k xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„28	Xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx	Xxxxxxxxxxxxxxx xxxxxxxxx	32289-58-0, 27083-27-8, 28757-47-3, 133029-32-0	608-723-9 608-042-7		0,1 %	Xxxxxxxxxx x aplikacích, xxx xxxxx xxxx x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxx xxxxxxxxxx.“

(*1)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx 2005/36/ES xx xxx 7. září 2005 x xxxxxxxx xxxxxxxxx xxxxxxxxxxx (Xx. xxxx. L 255, 30.9.2005, x.&xxxx;22).“

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.